VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,674 | -10.6% | 4,187 | 0.0% | 0.08% | -6.7% |
| Q2 2023 | $126,073 | -6.9% | 4,187 | 0.0% | 0.09% | -11.9% |
| Q1 2023 | $135,452 | +12.9% | 4,187 | 0.0% | 0.10% | +9.8% |
| Q4 2022 | $120,001 | +21.2% | 4,187 | +1.7% | 0.09% | +15.0% |
| Q3 2022 | $99,000 | -12.4% | 4,119 | 0.0% | 0.08% | -2.4% |
| Q2 2022 | $113,000 | -28.5% | 4,119 | 0.0% | 0.08% | -7.9% |
| Q1 2022 | $158,000 | +19.7% | 4,119 | 0.0% | 0.09% | +27.1% |
| Q4 2021 | $132,000 | +4.8% | 4,119 | -3.4% | 0.07% | -5.4% |
| Q3 2021 | $126,000 | -29.6% | 4,264 | -19.1% | 0.07% | -26.0% |
| Q2 2021 | $179,000 | -2.7% | 5,269 | -7.1% | 0.10% | -11.5% |
| Q1 2021 | $184,000 | -56.0% | 5,671 | -51.2% | 0.11% | -24.2% |
| Q4 2020 | $418,000 | – | 11,626 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |